Glioma Clinical Trials in Beijing, Beijing Municipality
18 recruitingBeijing, Beijing Municipality, China
Showing 1–18 of 18 trials
Recruiting
Phase 2
Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Solid Tumors With HIF-2α Related Genetic Alterations (MK-6482-015)
Pancreatic Neuroendocrine TumorVon Hippel-Lindau DiseasePheochromocytoma/Paraganglioma+2 more
Merck Sharp & Dohme LLC322 enrolled84 locationsNCT04924075
Recruiting
Clinical, patHOlogical and Imaging Project of nEuro-oncology (HOPE)
Brain TumorGliomaBrain (Nervous System) Cancers
Yaou Liu70,000 enrolled1 locationNCT05859659
Recruiting
Phase 3
SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
GliomaAstrocytoma, IDH-Mutant, Grade 2Astrocytoma, Grade IV+5 more
Nuvation Bio Inc.365 enrolled45 locationsNCT05303519
Recruiting
Not Applicable
Al18F-NOTA-LM3 PET/CT in Patients With Pheochromocytoma and Paraganglioma
Pheochromocytoma/Paraganglioma (PPGL)
Peking Union Medical College Hospital40 enrolled1 locationNCT07288931
Recruiting
Phase 1
A Study of GNC-039, a Tetra-specific Antibody, in Participants With Relapsed/Refractory or Metastatic Solid Tumors
Solid TumorRecurrent Glioma
Sichuan Baili Pharmaceutical Co., Ltd.60 enrolled6 locationsNCT04794972
Recruiting
Phase 1
BC008-1A Injection for Recurrent CNS WHO G4 Glioma
GliomaGlioblastoma WHO Grade IVGlioma Tumor Recurrence+2 more
Sichuan Luzhou Buchang Biopharmaceutical Co., Ltd.40 enrolled1 locationNCT06773481
Recruiting
Phase 1
Safety and Efficacy Study for DC Vaccine in Recurrent or Progressive High-grade Gliomas
WHO Grade III GliomasWHO Grade IV Gliomas
Beijing Tiantan Hospital12 enrolled1 locationNCT06253234
Recruiting
Detection of Microplastics and Nanoplastics in Neurosurgery Patients (DT-MiNi)
Brain TumorGliomaCarotid Artery Stenosis+2 more
Beijing Tiantan Hospital500 enrolled1 locationNCT05968053
Recruiting
Phase 1Phase 2
A Phase 2 Study of HX301 in Patients with High-grade Giloma
Glioma
Hangzhou Hanx Biopharmaceuticals, Ltd.72 enrolled1 locationNCT06703255
Recruiting
Not Applicable
Recurrent High Grade Glioma Treated by LITT
Recurrent High Grade Glioma
Beijing Tiantan Hospital135 enrolled9 locationsNCT06161610
Recruiting
Phase 1Phase 2
TIL Therapy Combined With Pembrolizumab for Advanced Brain Cancer Including Gliomas and Meningiomas
Brain MetastasesBrain TumorBrain Cancer+4 more
Essen Biotech85 enrolled1 locationNCT06640582
Recruiting
Phase 1
Clinical Study on the Safety and Efficacy of TS-2021 in the Treatment of Recurrent Malignant Glioma
Glioblastoma MultiformeGlioma, Malignant
Beijing Neurosurgical Institute30 enrolled1 locationNCT06585527
Recruiting
Not Applicable
Study on Radiogenomics Features Associated With Radiochemotherapy Sensitivity in Gliomas
Glioma
Beijing Tiantan Hospital200 enrolled1 locationNCT06454097
Recruiting
Early Phase 1
68Ga-NOTA-RM26 PET/CT in Glioma Patients
Glioma
Peking Union Medical College Hospital30 enrolled1 locationNCT06412952
Recruiting
Not Applicable
Evaluate the Effectiveness and Safety of Raman IVD Analyzer in the Molecular Diagnosis of Gliomas During Surgery
Glioma
Beijing Tiantan Hospital200 enrolled1 locationNCT06363162
Recruiting
Phase 1
Oncolytic Virus Ad-TD-nsIL12 for Progressive Pediatric Diffuse Intrinsic Pontine Glioma
Adverse Drug EventDiffuse Intrinsic Pontine GliomaOncolytic Virus
Capital Medical University18 enrolled1 locationNCT05717699
Recruiting
Phase 1
Oncolytic Virus Ad-TD-nsIL12 for Primary Pediatric Diffuse Intrinsic Pontine Glioma
Adverse Drug EventDiffuse Intrinsic Pontine GliomaOncolytic Virus
Capital Medical University18 enrolled1 locationNCT05717712
Recruiting
Genetic and Molecular Risk Profiles of Pediatric Malignant Brain Tumors in China
Germ Cell TumorGliomaBrain Tumor, Pediatric+3 more
Beijing Tiantan Hospital400 enrolled1 locationNCT05672043